Close Menu

Minnesota Partnership for Biotechnology and Medical Genomics

The partnership will provide $1.4 million in new funding for Mayo Clinic and University of Minnesota-led projects using genomics to understand and potentially treat human cancer.

A bill by the representative from Rochester would return the University of Minnesota and Mayo Clinic partnership funding level to the original $8 million per year.

The partnership between Mayo Clinic and the University of Minnesota will probably be a target as a budget-challenged state looks to slash spending.

The joint research collaboration of the Mayo Clinic and the University of Minnesota plans to lead a multi-institutional effort to translate diabetes research into improved yet lower-cost treatments, if not a cure, for the disease within 10 years.

The Minnesota Partnership for Biotechnology and Medical Genomics, a partnership of the University of Minnesota and Mayo Clinic, is making up to $4 million available in awards to researchers for human health and disease studies that the institutions cannot carry out individually.

The partners have formed the Frontiers of Biomedical Research with initial plans to establish fellowships for promising young investigators toward exchanges in specific research areas.

The Minnesota Partnership for Biotechnology and Medical Genomics will see its annual budget reduced by more than $1 million — to just under $7 million — in the fiscal year that begins July 1, following a $591,000 cut included in a budget deal reached this week by Gov. Tim Pawlenty and state legislative leaders.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.